Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudio Viscoli

Showing results (61-70 of 233) with videos related to

Pageof 24
Sort By:
JAMA Neurology|April 9, 2019
Fulminant Hepatitis Associated With Echovirus 25 During Treatment With Ocrelizumab for Multiple SclerosisLaura Ambra Nicolini, Paola Canepa, Patrizia Caligiuri, et al.
Current Drug Safety|November 30, 2011
Nevirapine-based regimens in routine clinical settings: results from a large Italian cohort of HIV-1 infected adultsRaffaella Rosso, Roberto Rossotti, Antonio Di Biagio, et al.
AIDS Research and Human Retroviruses|December 13, 2016
Exophytic Lesion of the Tongue in a Patient with Undetectable HIV-RNA in the Past 3 YearsFilippo Del Puente, Niccolò Riccardi, Nataniele Gioele Piol, et al.
AIDS Patient Care and Stds|April 1, 2008
Successful rescue therapy with Raltegravir (MK-0518) and Etravirine (TMC125) in an hiv-infected patient failing all four classes of antiretroviral drugsAntonio Di Biagio, Bianca Bruzzone, Raffaella Rosso, et al.
Clinicoeconomics and Outcomes Research : CEOR|December 14, 2011
Cost-effectiveness analysis of initial HIV treatment under Italian guidelinesGiorgio L Colombo, Vincenzo Colangeli, Antonio Di Biagio, et al.
Journal of Medical Virology|September 15, 2011
Lamivudine resistance mutations in European patients with hepatitis B and patients co-infected with HIV and hepatitis BLucia Taramasso, Patrizia Caligiuri, Antonio Di Biagio, et al.
Recent Patents on Anti-Infective Drug Discovery|July 18, 2014
Which patients have greatest need for elvitegravir/cobicistat/ emtricitabine/tenofovirDF-based therapy?Antonio Di Biagio, Roberta Prinapori, Lucia Taramasso, et al.
BMC Microbiology|June 8, 2014
Identification of a New Delhi metallo-β-lactamase-4 (NDM-4)-producing Escherichia coli in ItalyErika Coppo, Valerio Del Bono, Francesco Ventura, et al.
The New Microbiologica|July 11, 2007
Epidemiology and risk factors for bloodstream infections after allogeneic hematopoietic stem cell transplantionPaola Cappellano, Claudio Viscoli, Paolo Bruzzi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 12, 2021
Pneumocystis jirovecii Disease: Basis for the Revised EORTC/MSGERC Invasive Fungal Disease Definitions in Individuals Without Human Immunodeficiency VirusKatrien Lagrou, Sharon Chen, Henry Masur, et al.
Pageof 24

Showing results (61-70 of 233) with videos related to

Sort By:
Pageof 24
JAMA Neurology|April 9, 2019
Fulminant Hepatitis Associated With Echovirus 25 During Treatment With Ocrelizumab for Multiple SclerosisLaura Ambra Nicolini, Paola Canepa, Patrizia Caligiuri, et al.
Current Drug Safety|November 30, 2011
Nevirapine-based regimens in routine clinical settings: results from a large Italian cohort of HIV-1 infected adultsRaffaella Rosso, Roberto Rossotti, Antonio Di Biagio, et al.
AIDS Research and Human Retroviruses|December 13, 2016
Exophytic Lesion of the Tongue in a Patient with Undetectable HIV-RNA in the Past 3 YearsFilippo Del Puente, Niccolò Riccardi, Nataniele Gioele Piol, et al.
AIDS Patient Care and Stds|April 1, 2008
Successful rescue therapy with Raltegravir (MK-0518) and Etravirine (TMC125) in an hiv-infected patient failing all four classes of antiretroviral drugsAntonio Di Biagio, Bianca Bruzzone, Raffaella Rosso, et al.
Clinicoeconomics and Outcomes Research : CEOR|December 14, 2011
Cost-effectiveness analysis of initial HIV treatment under Italian guidelinesGiorgio L Colombo, Vincenzo Colangeli, Antonio Di Biagio, et al.
Journal of Medical Virology|September 15, 2011
Lamivudine resistance mutations in European patients with hepatitis B and patients co-infected with HIV and hepatitis BLucia Taramasso, Patrizia Caligiuri, Antonio Di Biagio, et al.
Recent Patents on Anti-Infective Drug Discovery|July 18, 2014
Which patients have greatest need for elvitegravir/cobicistat/ emtricitabine/tenofovirDF-based therapy?Antonio Di Biagio, Roberta Prinapori, Lucia Taramasso, et al.
BMC Microbiology|June 8, 2014
Identification of a New Delhi metallo-β-lactamase-4 (NDM-4)-producing Escherichia coli in ItalyErika Coppo, Valerio Del Bono, Francesco Ventura, et al.
The New Microbiologica|July 11, 2007
Epidemiology and risk factors for bloodstream infections after allogeneic hematopoietic stem cell transplantionPaola Cappellano, Claudio Viscoli, Paolo Bruzzi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 12, 2021
Pneumocystis jirovecii Disease: Basis for the Revised EORTC/MSGERC Invasive Fungal Disease Definitions in Individuals Without Human Immunodeficiency VirusKatrien Lagrou, Sharon Chen, Henry Masur, et al.
Pageof 24